Exploring the bold ideas, breakthrough technologies, and visionary people reshaping the future of AI and medicine.
TechBio Talks
Claim This Podcastby TechBio Talks
5.0(4 reviews)
7 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Exploring the bold ideas, breakthrough technologies, and visionary people reshaping the future of AI and medicine.
Language
🇺🇲
Publishing Since
8/21/2025
2 verified contact emails on file for TechBio Talks
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 11, 2026
TechBio Talks: Katie Couric and Najat Khan
<p>Recursion CEO and President Najat Khan talks to award-winning journalist, filmmaker, podcaster, and co-founder of Stand Up to Cancer, Katie Couric about their personal motivations; the current state of AI drug discovery; and exciting proof points like Recursion’s potential first-in-disease treatment for the rare disease familial adenomatous polyposis (FAP).</p>
December 16, 2025
TechBio Talks Episode 4: Highlander Health’s Amy Abernethy with Host Najat Khan
<p>In this episode of TechBio Talks, host Najat Khan, PhD, incoming CEO and President of Recursion, talks to Amy Abernethy, MD, PhD, cofounder of Highlander Health, about how structured, analyzable, real-world data is transforming healthcare and medicine.</p><p>Amy is a physician, innovator, and executive who has pioneered oncology real-world evidence generation to address gaps in patient care and access. </p><p>They discuss the three “waves” of real-world data leading to today’s multimodal data; how that real-world data ties into patients’ longitudinal health story; and the difference between real-world data and real-world evidence. And they dive into how this data is driving major innovative shifts to improve clinical trials and drug discovery. </p><p><br></p><p>⏱️ TIMESTAMPS ⏱️ </p><p>(00:00) Introduction.</p><p>(01:47) Defining Real-World Data (RWD) & Real-World Evidence (RWE): The difference between data as a byproduct of care and analyzed evidence.</p><p>(03:16) The Three Waves of RWD: From claims data to EHRs, and now multimodal, longitudinal data (genomics, imaging).</p><p>(05:49) Use Cases for RWE: Telling the story of what happened (retrospective) vs. planning for the future (clinical trial design).</p><p>(06:38) RWE in Drug Discovery: Combining deep biological data with clinical phenotypes to find new targets.</p><p>(09:14) Strategic Shift in Pharma: Moving RWE from a "replacement product" to a core strategic asset across the entire R&D lifecycle.</p><p>(11:06) Regulatory Evolution: How FDA guidance on data quality and curation is enabling broader RWE adoption.</p><p>(14:25) The Evidence Accelerator: How rapid-cycle meetings with the FDA during COVID-19 built regulatory familiarity with RWE.</p><p>(16:18) Introducing Highlander Health: A dual-model approach (non-profit institute + for-profit investment arm) to accelerate clinical research.</p><p>(21:48) AI’s Role in Evidence Generation: Using AI for data curation, study design optimization, and patient recruitment.</p><p>(24:41) The "Mantra": AI requires high-quality data; we must go back to the roots of getting the data right.</p><p>(27:47) What to Watch For: Disciplined, LLM-enabled data curation and the rise of prospective-retrospective hybrid study designs.</p><p><br></p>
October 27, 2025
TechBio Talks Episode 3: Air Street's Nathan Benaich with Host Chris Gibson
<p>The third episode of TechBio Talks features host Chris Gibson in conversation with leading AI investor Nathan Benaich of Air Street Capital. Learn about the evolving landscape of AI in drug discovery, the biggest trends identified in Nathan’s new State of AI Report, and what AI investors are looking for, now and in the future.<br></p>
7 total episodes available
Deep-dive analytics for TechBio Talks
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is TechBio Talks?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.